02/14/2025
8:30 PM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Singer Nicholas Jason (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
7:36 PM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
4:54 PM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
6:00 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Luther Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | Cicala Peter (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | Bristol James Arthur (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:00 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Wexler William A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
4:31 PM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
01/14/2025
4:00 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/14/2025
4:01 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NTN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NTN Buzztime and its competitors with MarketBeat's FREE daily newsletter. |
11/18/2024
3:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024
3:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024
3:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/17/2024
11:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form EFFECT | |
11/14/2024
5:45 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/14/2024
5:45 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/05/2024
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/05/2024
11:42 AM | Cherington Charles (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form ARS | |
09/27/2024
3:47 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
09/27/2024
3:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:36 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
4:00 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
3:32 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:14 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:30 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-K/A | |
